Are You Looking To Buy HealthEquity Inc. (HQY)? First, Read This


HealthEquity Inc. (NASDAQ:HQY) finished Thursday with a subtraction of -$2.89 to close at $70.61, a downside of -3.93 percent. An average of 768,084 shares of common stock have been traded in the last five days. There was a fall of -$0.14 in the past week, and it reached a new high 6 times over the past 12 months. The last 20 days have seen an average of 878,121 shares traded, while the 50-day average volume stands at 672,196.

HQY stock has increased by 21.29% in the last month. The company shares reached their 1-month lowest point of $59.91 on 08/24/22. With the stock rallying to its 52-week high on 09/22/22, shares of the company touched a low of $36.81 and a high of $74.04 in 52 weeks. It has reached a new high 36 times so far this year and achieved 66.14% or $26.98 in price. In spite of this, the price is down -4.63% from the 52-week high.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Insider Transactions

3 days have passed since HealthEquity Inc. (HQY) last reported insider trading activity. Sacks Ian, who is Director, most recently acquired $25,000 shares at $72.28 per share on Sep 20. In this transaction, the insider spent $1,806,925. CHIEF OPERATING OFFICER, Bloomberg Edward, disposed of 1,000 shares at a price of $57.63 on Aug 01. The insider now owns more than $57,630 worth of shares. Prior to that, CHIEF OPERATING OFFICER Bloomberg Edward went on to Sale 1,500 shares at $63.31 each on Jun 09. An amount of $94,959 was transacted.

Valuation Metrics

HealthEquity Inc. (HQY) stock’s beta is 0.87. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 7.95, the price-to-book (PB) ratio at 3.33, and the price-to-cash flow ratio at 54.88.

Financial Health

The quick ratio of HealthEquity Inc. for the three months ended July 30 was 2.50, and the current ratio was 2.50, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.49 and a total debt to equity ratio of 0.50 for the quarter ending July 30. Its gross profit as reported stood at $423.71 million compared to revenue of $756.56 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, HealthEquity Inc.’s return on assets was -2.00%.

Earnings Surprise

For the three-month period that ended July 30, HealthEquity Inc. had $914.97 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$10.65 million in the quarter, while revenues of -$13.64 million were grew 64.13%. The analyst consensus anticipated HealthEquity Inc.’s latest quarter earnings to come in at $0.33 per share, but it turned out to be $0.33, a 0.00% surprise. For the quarter, EBITDA amounted to $39.16 million. Shareholders own equity worth $84.53 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at HealthEquity Inc. (HQY) price momentum. RSI 9-day as of the close on 22 September was 60.38%, suggesting the stock is Neutral, with historical volatility in this time frame at 29.44%.

As of today, HQY’s price is $71.92 -0.20% or -$0.14 from its 5-day moving average. HQY is currently trading +13.37% higher than its 20-day SMA and +11.42% higher than its 100-day SMA. However, the stock’s current price level is +24.84% above the SMA50 and +66.67% above the SMA200.

The stochastic %K and %D were 85.22% and 85.53%, respectively, and the average true range (ATR) was 2.69. With the 14-day stochastic at 75.61% and the average true range at 2.60, the RSI (14) stands at 62.57%. The stock has reached 0.54 on the 9-day MACD Oscillator while the 14-day reading was at 2.65.

Analyst Ratings

KeyBanc Capital Markets launched coverage on HealthEquity Inc. (NASDAQ: HQY) in its analyst report released on September 16, 2022. The firm assigned the stock an Overweight rating. The consensus rating for HealthEquity Inc. (HQY) among analysts is Overweight. According to current brokerage recommendations, 1 brokerage firm advise that investors sell HQY, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 11 others rate it as a “buy”.

What is HQY’s price target for the next 12 months?

Analysts predict a range of price targets between $64.00 and $100.00, with a median target of $78.00. Taking a look at these predictions, the average price target given by analysts for HealthEquity Inc. (HQY) stock is $79.07.


Please enter your comment!
Please enter your name here